Management of SSRI-induced sexual dysfunction

Annals of Pharmacotherapy

Volumn 32, Issue 11, 1998, Pages 1209-1215

  Woodrum, Sharon T ^a   Brown, Candace S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antidepressants; Selective serotonin reuptake inhibitors; Sexual dysfunction

Indexed keywords

AMANTADINE; AMFEBUTAMONE; BUSPIRONE; CLOMIPRAMINE; CYPROHEPTADINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLUVOXAMINE; GRANISETRON; METHYLPHENIDATE; NEFAZODONE; PAROXETINE; PEMOLINE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; YOHIMBINE;

ANORGASMIA; CLINICAL TRIAL; HUMAN; LIBIDO; PENIS ERECTION; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; TREATMENT OUTCOME;

EID: 0031755092     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17428     Document Type: Review

References (49)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
2. Prisant LM, Carr AA, Bottini PB, Solursh DS, Solursh LP. Sexual dysfunction with antihypertensive drugs. Arch Intern Med 1994;154:730-6.
3. Gitlin MJ. Effects of depression and antidepressants on sexual functioning. Bull Menninger Clin 1995;59:232-48.
4. Segraves T. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989;46:275-84.
5. Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994;55: 406-13.
6. Segraves RT. Overview of sexual dysfunction complicating the treatment of depression. J Clin Psychiatry Monogr 1992;10:4-10.
7. Davidson JRT. Sexual dysfunction and antidepressants. Depression 1994/1995;2:233-40.
8. Prescribing information. Prozac (fluoxetine). Indianapolis: Eli Lilly, 1995.
9. Prescribing information. Zoloft (sertraline). New York: Pfizer, 1995.
10. Prescribing information. Paxil (paroxetine). Philadelphia: SmithKline-Beecham, 1994.
11. Prescribing information. Luvox (fluvoxamine). Marietta, GA: Solvay, 1994.
12. Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 1990;51:25-7.
13. Zajecka J, Fawcett J, Schaff M, Jeffriess H, Guy C. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 1991;52:66-8.
14. Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119-22.
15. Patterson WM. Fluoxetine-induced sexual dysfunction (letter). J Clin Psychiatry 1993;54:71.
16. Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993;54:209-12.
17. Fisher S, Kent TA, Bryant SG. Postmarketing surveillance by patient self monitoring: preliminary data for sertraline versus fluoxetine. J Clin Psychiatry 1995;56:288-96.
18. Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, et al. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990;51(12 suppl B): 18-27.
19. Grimsley SR, Jann MW. Paroxetine, sertraline and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharm 1992;11:930-57.
20. McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry 1990; 51:383-4.
21. Goldbloom DS, Kennedy SH. Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. J Clin Psychiatry 1991;52:261-2.
22. Cohen AJ. Fluoxetine-induced yawning and anorgasmia reversed by cyproheptadine treatment (letter). J Clin Psychiatry 1992;53:174.
23. Amott S, Nutt D. Successful treatment of fluvoxamine-induced anorgasmia by cyproheptadine. Br J Psychiatry 1994;164:838-9.
24. Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry 1991;52:163-4.
25. McGilp R. Case report (2): paroxetine and delayed ejaculation - a treatable side effect. J Drug Dev 1993;5:265-6.
26. Aizenberg D, Zemishlany Z, Weizman A. Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 1995;18:320-4.
27. Segraves RT. Treatment of drug-induced anorgasmia (letter). Br J Psychiatry 1994;165:554.
28. Singh AN, Scurlock H, Catalan J. Paroxetine induced erectile dysfunction successfully treated with yohimbine in patients suffering from HIV infection. J Serotonin Res 1995;1:283-5.
29. Balogh S, Hendricks SE, Kang J. Treatment of fluoxetine-induced anorgasmia with amantadine (letter). J Clin Psychiatry 1992;53:212-3.
30. Shrivastava RK, Shrivastava S, Overweg N, Schmitt M. Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors (letter). J Clin Psychopharmacol 1995;15:83-4.
31. Masand PS, Reddy N, Gregory R. SSRI-induced sexual dysfunction successfully treated with amantadine. Depression 1994/1995;2:319-21.
32. Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther 1996;22:290-1.
33. Gitlin MJ. Treatment of sexual side effects with dopaminergic agents (letter). J Clin Psychiatry 1995;56:124.
34. Bartlik BD, Kaplan P, Kaplan HS. Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J Sex Marital Ther 1995;21:264-71.
35. Labbate LA, Pollack MH. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry 1994;6:13-5.
36. Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998;59:112-5.
37. Reynolds R. Sertraline-induced anorgasmia treated with intermittent nefazodone (letter). J Clin Psychiatry 1997;58:89.
38. Norden MJ. Buspirone treatment of sexual dysfunction associated with selective serotonin re-uptake inhibitors. Depression 1994/1995;2:109-12.
39. 3 antagonist granisetron (letter). J Clin Psychiatry 1997;58:496-7.
40. Segraves RT. Treatment-emergent sexual dysfunction in affective disorders: a review and management strategies. J Clin Psychiatry Monogr 1993;11:57-60.
41. Beasley CM, Bosomworth JC, Wemicke JF. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression. Psychopharmacol Bull 1990;26:18-24.
42. Gardner EA, Johnston JA. Bupropion - an antidepressant without sexual pathophysiological action. J Clin Psychopharmacol 1985;5:24-9.
43. Data on file. Medical Affairs Department. Princeton, NJ: Bristol-Myers Squibb Company, 1996.
44. Rickeis K, Schweizer E, Clary C, Fox I, Weise C. Nefazodone and imipramine in major depression: a placebo controlled trial. Br J Psychiatry 1994;164:802-5.
45. Steele TE, Howell EF. Cyproheptadine for imipramine-induced anorgasmia (letter). J Clin Psychopharmacol 1986;6:326-7.
46. Price J, Grunhaus LJ. Treatment of clomipramine-induced anorgasmia with yohimbine: a case report. J Clin Psychiatry 1990;51:32-3.
47. Katz RJ, Rosenthal M. Adverse interaction of Cyproheptadine with serotonergic antidepressants. J Clin Psychiatry 1994;55:314-5.
48. Christensen RS. Adverse interaction of paroxetine and cyproheptadine (letter). J Clin Psychiatry 1995;56:433-4.
49. Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 1992;53:207-9.